Funding | Global Biodefense

Menu

Latest stories

test plate 96 well bioassay

BioFactura’s Smallpox Biodefense Therapeutic Awarded $67M BARDA Contract

Influenza virus particles

Center for Vaccine Development Awarded up to $201M to Establish Influenza Clinical Core

More on pathogens and preparedness

Popular

Project BioShield: Building a Better Medical Countermeasure Pipeline

by Global Biodefense August 5, 2019, 5:00 am
Detecting Infection Before Symptoms Occur by Monitoring the Vagus Nerve

by Stephanie Lizotte August 1, 2019, 5:36 pm
BARDA Exercises First Option in Transition from BioThrax to AV7909 Anthrax Vaccine
Popular

DHS Marks 1,000th SBIR Contract, Highlights Recent Investments in Rapid DNA and CWMD

by Global Biodefense June 24, 2019, 1:41 pm
Emergency Response and Recovery Supplemental Funding for GHSA Support

by Global Biodefense June 20, 2019, 7:47 am
Biological Threat Reduction: Design and Build Effluent Treatment System at Kenya’s FMD Vaccine Facility

by Global Biodefense June 18, 2019, 10:30 am
In Fight Against Superbugs, BARDA Looks to Shore Up National Stockpile Countermeasures
CDC RFI: Collection of Specimens During Outbreak or Public Health Emergency

by Global Biodefense June 17, 2019, 8:20 am
USAID Seeks Innovations in Malaria Vaccine Development

by Global Biodefense June 16, 2019, 10:53 am
USAMRIID Seeks Isolation and Purification of Ovatoxins

by Global Biodefense June 15, 2019, 11:12 am
DARPA Seeks First-in-Human Therapeutic Interfering Particles Targeting Respiratory Viruses
U.S. Supporting Ecological Surveillance for Special Pathogens in Sierra Leone

by Global Biodefense April 28, 2019, 3:29 am

Congratulations. You've reached the end of the internet.

Back to Top